Schizophrenia Drugs Market to Hit USD 12.78 Billion by 2032, Driven by Advancements in Atypical…
SNS Insider Highlights Surging Demand in the U.S. Schizophrenia Drugs Market—Valued at USD 2.84 Billion in 2024—As…
GlobeNewswire provides press release distribution services globally, with substantial operations in North America and Europe.